pindolol has been researched along with Leiomyosarcoma in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Leiomyosarcoma: A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scarpace, PJ | 1 |
| Baresi, LA | 1 |
| Sanford, DA | 1 |
| Abrass, IB | 1 |
1 other study available for pindolol and Leiomyosarcoma
| Article | Year |
|---|---|
Desensitization and resensitization of beta-adrenergic receptors in a smooth muscle cell line.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cell Line; Cricetinae; Glucocorticoids; Iodine | 1985 |